Xing Meng1, Ailian Liu 1, Shifeng Tian1, Zhiwei Shen2, Yaxin Niu1, Wan Dong1, Zhongping Zhang2, and Yishi Wang2
1Department of Radiology, the First Affiliated Hospital of Dalian Medical University, Dalian, China, 2Philips Healthcare, Beijing, China
Synopsis
Amide
proton transfer (APT) and mDixon - Quant techniques have been applied in
clinical work, but few studies have been conducted in female pelvic system. We
discussed the value of APT combined with R2* in differentiating
endometrial cancer from benign endometrial lesions. The AUC, sensitivity and
specificity of APT combined R2* were 0.925, 88% and 100%,
respectively.
INTRODUCTION
The
etiology of endometrial lesions is not clear, and the endometrial condition changes
with the menstrual cycle.The clinical manifestations of endometrial carcinoma
and endometrial benign lesions are more similar, so how to make an accurate
diagnosis of endometrial lesions is particularly important. Magnetic resonance imaging (MRI) is
increasingly being applied for diagnosing endometrial diseases and as a
problem-solving tool when there is a diagnostic dilemma, but differentiate
endometrial carcinoma from benign remains challenging [1]. APT weighted MRI uses the presence of
low-concentration solutes (such as mobile proteins and peptides) in tissues or
tumors that contain abundant amide chemical constituents to produce an MR
signal that directly correlates with cell proliferation [2]. Modified
Dixon (mDixon) Quant technique with six echoes, seven fat peaks and T2*
correction was found to enable robust water-fat separation and to have high
quality fat and R2* quantification[3] .APT and mDixon -Quant
techniques have been applied in clinical work, but few studies have been
conducted in female pelvic system. In this study, we would like to explored the
value of APT combined with R2* in the differential diagnosis of
endometrial carcinoma and endometrial benign lesions.METHODS
Data
of 8 cases of endometrial carcinoma and 5 cases of endometrial benign lesions
(4 cases of endometrial polyps and 1 case of endometrial hyperplasia) confirmed
by surgery and pathology were retrospectively analyzed. All patients received
3.0T routine MRI,APT and mDIXON -- Quant scans on a 3.0T MRI (Ingenia CX, Philips
Healthcare, Best, the Netherlands) equipment before surgery. Table 1 lists the detail of scan
parameters. According to the lesion area of endometrium on T2WI
and DWI, the ROI in the lesion area was drawn on the APT -T2WI fusion images by
two observers who were blindly to the pathological results. Then the APT value was
recorded . ROI was also plotted in the corresponding region of mDIXON - Quant
imaging to obtain the R2* value of the lesion. Intra-group
correlation coefficient (ICC) was used to test the consistency of measurement
results between the two observers. The rank sum test was used to analyze the
difference of each parameter between the two groups, and the AUC was calculated
to evaluate the diagnostic efficacy. For all tests, values of P <0.05 were
considered to indicate statistical significance.RESULTS
The
results of parameter values and consistency test were measured by two observers
in the two groups, and the numerical consistency was good in each group (Table
2), ICC>0.75. APT value and R2* in the endometrial carcinoma
group were both larger than those in the benign group, with statistically
significant differences (P<0.05). Specific results were shown in Table 3 and
Figure 1. The AUC values of APT, R2* and their combination were
shown in Table 4.DISCUSSION AND CONCLUSIONS
APT
value is affected by changes in protein concentration and PH value [4].
Tumor cells of endometrial carcinoma are metabolically active and their protein
concentration is higher than that of benign endometrial lesions, so APT value
is high, which is consistent with our results of this study that APT value of
endometrial carcinoma group is higher than that of benign endometrial lesions. Deoxyhemoglobin,
hemosiderin, noremoglobin and other paramagnetic substances can increase the R2*
value [5]. In this study, the R2* value of the
endometrial carcinoma group was higher than that of the endometrial benign
lesion group, and the reason may be that the concentration of paramagnetic
substances in the endometrial carcinoma tissues increased [6].The
combination of APT and R2* can improve the diagnostic ability of
discriminating endometrial carcinoma from endometrial benign lesions, which has
certain clinical application value.Acknowledgements
No acknowledgement.References
[1] Park BK, Kim B, Park JM, Ryu JA, Kim MS, Bae DS, Ahn GH. Differentiation of the various lesions causing an abnormality of the
endometrial cavity using MRI imaging: emphasis on enhancement. Patterns on
dynamic studies and late contrast-enhanced T1-weighted images. Eur Radiol. 2006;16:1591–1598.
[2] He YL, Li Y,
Lin CY, et al. Three-dimensional turbo-spin-echo amide proton transfer-weighted
MRI for cervical cancer: a preliminary study. J Magn Reson Imaging 2019. DOI: 10.1002/jmri.26710
[3] Kühn JP,
Hernando D, Meffert PJ, et al. Proton-density fat fraction and
simultaneous R2*
estimation as an MRI tool for assessment of osteoporosis.
Eur Radiol 2013;23:3432–3439.
[4] Ray KJ, Simard MA, Larkin JR, et al. Tumor pH and
Protein Concentration Contribute to the Signal of Amide Proton Transfer
Magnetic Resonance Imaging. Cancer Res 2019;
79:1343-1352.DOI:10.1158/0008-5472.CAN-18-2168
[5]İdilman
İS,Gümrük F,Haliloğlu M.The Feasibility of Magnetic Resonance Imaging for
Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal
Cortex R2* and Proton Density Fat Fraction in Transfusion-Related
Iron Overload.Turk J Haematol 2016;33:21-27.DOI:10.4274/tjh.2015.0142
[6] Yang X.The Role of Metabolic Syndrome in Endometrial
Cancer: A Review.FrontOncol 2019;9:744.